Journal Scan

No link between GH replacement and primary tumor or cancer recurrence

There does not appear to be an association between growth hormone (GH) replacement and primary tumor or cancer recurrence, according to a new consensus statement. Although the safety of GH therapy has been studied extensively, experimental studies raised the concern over the safety of GH replacement in patients who have received...